Table 1 Analysis of influencing factors of CMDLD

Years

2015

286

200(69.93%)

85,700.00 (33,750.00,213,825.00)

H = 38.251^a

(P < 0.001)

2016

288

145(50.35%)

120,400.00(43,900.00,227,047.11)

2017

267

93(34.83%)

177,611.00 (61,286.00,336,450.00)

2018

199

75(37.69%)

125,832.00 (68,634.00,242,106.00)

2019

277

82(29.60%)

93,329.50 (17,562.75,264,800.00)

2020

177

94(53.11%)

148,987.55 (30,810.08,313,946.55)

2021

296

250(84.46%)

191,897.83 (76,179.39,400,235.91)

Regions

Eastern

864

418(48.38%)

111,463.00(30,000.00,304428.90)

H = 9.692^a

(P = 0.008)

Middle

632

353(55.85%)

130,069.00(56,839.50,274042.00)

West

294

168(57.14%)

151,718.00(86,853.25,346,510.54)

Types of Hospitals

Township health center

95

53(55.79%)

90,100.00 (31,840.05,192,366.85)

H = 5.150^a

(P = 0.076)

County Hospital

328

188(57.32%)

140,215.75(57,697.03,279,120.48)

City/provincial hospital

1,367

698(51.06%)

135,258.00(46,790.75,317,765.41)

Patients’ purposes for appeal

Truth over claims

274

114(41.61%)

107,810.22(27,412.50,301,975.00)

Z=-1.355^b

(P = 0.175)

Claims over the truth

1,516

825(54.42%)

138,500.00(49,566.31,302,877.17)

Treatment Properties

Low Cost-effectiveness of treatment

68

19(27.94%)

20,000.00(6,100.00,296,051.35)

H = 90.491^a

(P < 0.001)

Poor treatment effect

165

64(38.79%)

30,000.00(10,000.00,92,502.07)

Complications of treatment

161

79(49.07%)

54,000.00(26,121.95,158,687.50)

Treatment leading to disability

636

378(59.43%)

110,663.50(47,280.25, 294,271.03)

Treatment leading to death

760

399(52.50%)

186,300.00(86,880.71,370,033.00)

Procedures

First trial

260

222(85.38%)

183,497.90(60,159.73,357,006.40)

H = 9.660^a

(P = 0.008)

Second trial

1,473

701(47.59%)

120,400.00(39,850.00,262,293.50)

Retrial

57

16(28.07%

127,525.50(70,000.00,555,213.00)